Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

MLA

Koyama, Shohei, et al. “Adaptive Resistance to Therapeutic PD-1 Blockade Is Associated with Upregulation of Alternative Immune Checkpoints.” Nature Communications, vol. 7, Feb. 2016, p. 10501. EBSCOhost, https://doi.org/10.1038/ncomms10501.

APA

Koyama, S., Akbay, E. A., Li, Y. Y., Herter-Sprie, G. S., Buczkowski, K. A., Richards, W. G., Gandhi, L., Redig, A. J., Rodig, S. J., Asahina, H., Jones, R. E., Kulkarni, M. M., Kuraguchi, M., Palakurthi, S., Fecci, P. E., Johnson, B. E., Janne, P. A., Engelman, J. A., Gangadharan, S. P., … Hammerman, P. S. (2016). Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints. Nature Communications, 7, 10501. https://doi.org/10.1038/ncomms10501

Chicago

Koyama, Shohei, Esra A Akbay, Yvonne Y Li, Grit S Herter-Sprie, Kevin A Buczkowski, William G Richards, Leena Gandhi, et al. 2016. “Adaptive Resistance to Therapeutic PD-1 Blockade Is Associated with Upregulation of Alternative Immune Checkpoints.” Nature Communications 7 (February): 10501. doi:10.1038/ncomms10501.